AB Science Valuation
| AB Stock | EUR 1.38 0.01 0.73% |
Today, the entity appears to be fairly valued. AB Science SA owns a latest Real Value of €1.36 per share. The recent price of the entity is €1.38. Our model approximates the value of AB Science SA from evaluating the entity fundamentals such as Operating Margin of (5.30) %, shares owned by institutions of 0.12 %, and Price To Earning of (10.99) X as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting AB Science's valuation include:
Enterprise Value | Enterprise Value Ebitda (25.97) | Price Sales 88.9338 | Enterprise Value Revenue 102.5803 |
Fairly Valued
Today
Please note that AB Science's price fluctuation is very risky at this time. Calculation of the real value of AB Science SA is based on 3 months time horizon. Increasing AB Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AB Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AB Science Stock. However, AB Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.38 | Real 1.36 | Hype 1.39 |
The real value of AB Science Stock, also known as its intrinsic value, is the underlying worth of AB Science SA Company, which is reflected in its stock price. It is based on AB Science's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AB Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AB Science SA helps investors to forecast how AB Science stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AB Science more accurately as focusing exclusively on AB Science's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use AB Science's intrinsic value based on its ongoing forecasts of AB Science's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against AB Science's closest peers. If more than one evaluation category is relevant for AB Science we suggest using both methods to arrive at a better estimate.
AB Science Cash |
|
AB Science Total Value Analysis
AB Science SA is presently projected to have takeover price of 105.35 M with market capitalization of 91.34 M, debt of 18.47 M, and cash on hands of 0. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AB Science fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
105.35 M | 91.34 M | 18.47 M | 0 |
AB Science Investor Information
About 31.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.15. AB Science SA had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from AB Science's historical financial statements, AB Science SA may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.AB Science Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AB Science has an asset utilization ratio of 4.63 percent. This suggests that the Company is making €0.0463 for each dollar of assets. An increasing asset utilization means that AB Science SA is more efficient with each dollar of assets it utilizes for everyday operations.AB Science Profitability Analysis
Based on the measurements of profitability obtained from AB Science's financial statements, AB Science SA may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess AB Science's ability to earn profits and add value for shareholders.Net Loss | First Reported 2008-12-31 | Previous Quarter -3.4 M | Current Value -5.2 M | Quarterly Volatility 3.6 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.66 | 1.05 |
|
|
For AB Science profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AB Science SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AB Science utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AB Science's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AB Science over time as well as its relative position and ranking within its peers.
AB Science Earnings per Share Projection vs Actual
By analyzing AB Science's earnings estimates, investors can diagnose different trends across AB Science's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for AB Science SA is based on EPS before non-recurring items and includes expenses related to employee stock options. AB Science is projected to generate -0.1025 in earnings per share on the 31st of December 2024. AB Science earnings estimates show analyst consensus about projected AB Science EPS (Earning Per Share). It derives the highest and the lowest estimates based on AB Science's historical volatility. Many public companies, such as AB Science, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.AB Science Ownership Allocation
AB Science SA secures a total of 66.18 Million outstanding shares. AB Science SA shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.AB Science Profitability Analysis
The company reported the revenue of 1.07 M. Net Loss for the year was (7.83 M) with profit before overhead, payroll, taxes, and interest of 932 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AB Science's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AB Science and how it compares across the competition.
About AB Science Valuation
The stock valuation mechanism determines AB Science's current worth on a weekly basis. Our valuation model uses a comparative analysis of AB Science. We calculate exposure to AB Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AB Science's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.4 M | 1.3 M | |
| Pretax Profit Margin | (6.58) | (6.90) | |
| Operating Profit Margin | (5.11) | (5.36) | |
| Net Loss | (6.57) | (6.90) | |
| Gross Profit Margin | 1.05 | 0.66 |
Complementary Tools for AB Science Stock analysis
When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |